Multiple signaling pathways, such as the ﻿epithelial growth factor receptor (EGFR), Wnt/β-catenin, NF-κB, and transforming growth factor-beta pathways, are involved in CRC development. The gene discussed is EGFR; the disease is colorectal carcinoma.